Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DTC Genetic Testing Debated As Public Obtains Broader Access To Kits

This article was originally published in The Gray Sheet

Executive Summary

DNA Direct - a company that sells genetic tests directly to consumers and provides counseling and interpretation of the results - plans to launch a panel of infertility assays in May

You may also be interested in...



FDA, Agendia To Determine Scope Of MammaPrint Premarket Regulation

Agendia's MammaPrint breast cancer recurrence assay may qualify for a CLIA waiver and require no further premarket regulation, the company says

FDA, Agendia To Determine Scope Of MammaPrint Premarket Regulation

Agendia's MammaPrint breast cancer recurrence assay may qualify for a CLIA waiver and require no further premarket regulation, the company says

ASR Guidance Development May Be Supported By AdvaMed FAQ Document

AdvaMed plans to revise a set of frequently asked questions related to analyte specific reagents that could be used as a starting point for an FDA guidance document, following a recent meeting with the agency

Related Content

UsernamePublicRestriction

Register

MT021982

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel